Table 2 Simple and multiple linear regression model (estimated value [95% confidence intervals]) for post index date of pneumonia (post-ID pneumonia) periods in total chronic rhinosinusitis compared to control group and subgroup analysis according to age and sex.

From: Association between chronic rhinosinusitis and pneumonia: a longitudinal follow-up study using a national health screening cohort

Characteristics

Mean ± SD in

CRS total group

Mean ± SD in

control group

Linear regression of CRS for pneumonia

Simpleb

P value

Model 1b,c

P value

Model 2b,d

P value

Total participants (n = 31,965)

1-y post-ID pneumonia

0.08 ± 0.67

0.05 ± 0.54

0.030 (0.015 to 0.046)

 < 0.001a

0.008 (− 0.007 to 0.024)

0.305

0.015 (− 0.001 to 0.030)

0.059

2-y post-ID pneumonia

0.08 ± 0.57

0.05 ± 0.58

0.027 (0.011 to 0.042)

0.001a

0.004 (− 0.012 to 0.019)

0.651

0.008 (− 0.008 to 0.024)

0.310

3-y post-ID pneumonia

0.08 ± 0.65

0.05 ± 0.52

0.033 (0.018 to 0.048)

 < 0.001a

0.013 (− 0.002 to 0.028)

0.079

0.017 (0.002 to 0.031)

0.030a

Age < 60 years old (n = 21,630)

1-y post-ID pneumonia

0.05 ± 0.51

0.03 ± 0.36

0.023 (0.010 to 0.036)

0.001a

0.009 (− 0.005 to 0.022)

0.204

0.012 (− 0.001 to 0.025)

0.065

2-y post-ID pneumonia

0.05 ± 0.44

0.03 ± 0.35

0.021 (0.009 to 0.034)

0.001a

0.009 (− 0.003 to 0.022)

0.141

0.012 (− 0.001 to 0.024)

0.060

3-y post-ID pneumonia

0.06 ± 0.61

0.03 ± 0.33

0.036 (0.022 to 0.049)

 < 0.001a

0.023 (0.009 to 0.036)

0.001a

0.025 (0.011 to 0.038)

 < 0.001a

Age ≥ 60 years old (n = 10,335)

1-y post-ID pneumonia

0.15 ± 0.91

0.10 ± 0.80

0.045 (0.006 to 0.085)

0.024a

0.014 (− 0.026 to 0.053)

0.498

0.025 (− 0.014 to 0.063)

0.206

2-y post-ID pneumonia

0.14 ± 0.79

0.10 ± 0.88

0.038 (− 0.003 to 0.079)

0.071

0.000 (− 0.041 to 0.041)

0.997

0.008 (− 0.033 to 0.048)

0.717

3-y post-ID pneumonia

0.12 ± 0.73

0.09 ± 0.77

0.027 (− 0.009 to 0.064)

0.144

0.000 (− 0.037 to 0.037)

0.999

0.005 (− 0.032 to 0.041)

0.798

Males (n = 19,400)

1-y post-ID pneumonia

0.07 ± 0.57

0.06 ± 0.56

0.018 (− 0.001 to 0.038)

0.066

− 0.005 (− 0.024 to 0.015)

0.638

0.001 (− 0.018 to 0.020)

0.943

2-y post-ID pneumonia

0.08 ± 0.58

0.05 ± 0.59

0.024 (0.004 to 0.044)

0.021a

0.000 (− 0.020 to 0.021)

0.988

0.004 (− 0.016 to 0.024)

0.711

3-y post-ID pneumonia

0.08 ± 0.61

0.05 ± 0.57

0.030 (0.010 to 0.050)

0.003a

0.011 (− 0.010 to 0.031)

0.303

0.013 (− 0.007 to 0.033)

0.202

Females (n = 12,565)

1-y post-ID pneumonia

0.10 ± 0.80

0.05 ± 0.52

0.048 (0.023 to 0.074)

 < 0.001a

0.028 (0.003 to 0.054)

0.030a

0.037 (0.012 to 0.062)

0.004a

2-y post-ID pneumonia

0.08 ± 0.57

0.04 ± 0.56

0.031 (0.006 to 0.056)

0.013a

0.008 (− 0.017 to 0.033)

0.535

0.014 (− 0.011 to 0.038)

0.278

3-y post-ID pneumonia

0.08 ± 0.71

0.04 ± 0.43

0.038 (0.016 to 0.060)

0.001a

0.018 (− 0.004 to 0.041)

0.103

0.022 (0.000 to 0.044)

0.046a

  1. Abbreviations: CCI, Charlson comorbidity index; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; CRS, chronic rhinosinusitis; 1-y pre-ID pneumonia, pneumonia history from the date of CRS treatment (index date) to the date before 1-year periods; Post-ID pneumonia, the number of pneumonia diagnosis from the index date to the date after certain periods; SBP, systolic blood pressure; SD, standard deviation.
  2. aLinear regression model, Significance at P < 0.05.
  3. bModels were stratified by age, sex, income, and region of residence.
  4. cA model 1 was adjusted for obesity, smoking, alcohol consumption, total cholesterol, SBP, DBP, fasting blood glucose, CCI scores, asthma, and COPD.
  5. dA model 2 was adjusted for the model 1 plus 1-y pre-ID pneumonia.